Oxford PV collaborates with HZB to move perovskite solar cells closer to commercialisation
Oxford PV – The Perovskite Company's industrial site in Brandenburg an der Havel, Germany where the company is working rapidly to transfer its advanced perovskite on silicon tandem solar cell technology to an industrial scale process. © Oxford PV
Perovskite solar technology leader Oxford PV collaborates with leading German research centre to support the accelerated transfer of its technology into silicon cell manufacturing lines.
Oxford PVTM – The Perovskite CompanyTM, the leader in the field of perovskite solar cells, today announced its collaboration with Helmholtz-Zentrum Berlin (HZB), the leading German research centre focused on energy materials research.
Oxford PV has made considerable progress in transferring its advanced perovskite on silicon tandem solar cell technology from its laboratory in Oxford, UK to an industrial scale process at its site in Brandenburg an der Havel, Germany.
HZB’s extensive expertise in silicon heterojunctions solar cell technology, will support Oxford PV to further optimise its perovskite on silicon tandem solar cell technology, and demonstrate production scale up, to ensure ease of integration into large scale silicon solar cell and module production.
“Working with HZB to understand solar cell manufacturers’ silicon cells, will allow Oxford PV’s perovskite on silicon tandem formation to be fully optimised, to ensure the most efficient tandem solar cell, and the easy transfer of our technology into our commercial partner’s industrial processes, commented Chris Case, Chief Technology Officer, at Oxford PV,
“Oxford PV is now in the final stage of commercialising its perovskite photovoltaic solution, which has the potential to enable efficiency gains that will transform the economics of silicon photovoltaic technology globally.”
Rutger Schlatmann, Director of the PVcomB institute at HZB, said, “HZB believe that perovskites present a significant opportunity to the future of photovoltaics. For this reason, at our new innovation lab - HySPRINT, we have significantly increased our expertise and attracted some of the most promising young scientists in this field. HZB’s collaboration with Oxford PV is strategically important to the institute, as Oxford PV is the ideal partner to further develop our solar cell technology knowledge and help support the commercialisation of tandem silicon perovskite photovoltaic cells.”
More Information:
- Oxford PV
- PVcomB
- HySPRINT-a Helmholtz Innovation Lab
- Green hydrogen: MXenes shows talent as catalyst for oxygen evolutionThe MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
- SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beerThe first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
- Review on ocular particle therapy (OPT) by international expertsA team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.